Profile
Hartmut Retzlaff is currently a Director at Clonmel Healthcare Ltd., STADA Financial Investments Ltd., STADA Pharmaceuticals (Asia) Ltd., and a Member-Supervisory Board at Eurogenerics NV, STADApharm AB, and Stada Vietnam J.V.
Co. Ltd.
He was formerly the Chairman-Management Board at STADA Arzneimittel AG from 1992 to 2016.
He also held positions as Chairman at Hemofarm AD, Director at OY Stada Pharma AB and SFS International Ltd., and Member-Supervisory Board at NeoCare NV.
Hartmut Retzlaff active positions
| Companies | Position | Start |
|---|---|---|
| Eurogenerics NV | Director/Board Member | - |
Clonmel Healthcare Ltd.
 Clonmel Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Clonmel Healthcare Ltd. manufactures pharmaceutical products. Its prescription products therapeutic areas including CNS, cardiovascular, NSAID, gastro-intestinal and anti-infectives. The firm's products focus on women's and babies health, skincare and health supplements. The company was founded by T. O'Brien in 1970 and is headquartered in Dublin, Ireland. | Director/Board Member | - |
| STADA Financial Investments Ltd. | Director/Board Member | - |
| STADApharm AB | Director/Board Member | - |
| STADA Pharmaceuticals (Asia) Ltd. | Director/Board Member | - |
| Stada Vietnam J.V. Co. Ltd. | Director/Board Member | 2013-08-31 |
Former positions of Hartmut Retzlaff
| Companies | Position | End |
|---|---|---|
| STADA ARZNEIMITTEL | Chief Executive Officer | 2016-06-04 |
| SFS International Ltd. | Director/Board Member | - |
| OY Stada Pharma AB | Director/Board Member | - |
| ░░░░░░░░ ░░ | ░░░░░░░░ | - |
| ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 11 |
|---|---|
STADA Arzneimittel AG
 STADA Arzneimittel AG Pharmaceuticals: OtherHealth Technology STADA Arzneimittel AG engages in the provision of healthcare and pharmaceutical products. It operates through the following segments: Generics, Consumer Healthcare, and Specialty. The Generics segment produces and distributes generic drugs. The Consumer Healthcare segment includes products such as OTC drugs, nutritional supplements and certain consumer healthcare products such as disinfectants and sunscreen. The Specialty segment includes branded generics, specialty generics, and biosimilars. Its brands include Zoflora, Grippostad, Nizoral, and Shampoo & Ladival. The company was founded on March 14, 1895 and is headquartered in Bad Vilbel, Germany. | Health Technology |
Hemofarm AD
 Hemofarm AD Pharmaceuticals: MajorHealth Technology Hemofarm AD engages in the manufacture, sale, and distribution of pharmaceutical products. The company was founded on June 1, 1960 and is headquartered in Vrsac, Serbia. | Health Technology |
Clonmel Healthcare Ltd.
Clonmel Healthcare Ltd. Pharmaceuticals: MajorHealth Technology Clonmel Healthcare Ltd. manufactures pharmaceutical products. Its prescription products therapeutic areas including CNS, cardiovascular, NSAID, gastro-intestinal and anti-infectives. The firm's products focus on women's and babies health, skincare and health supplements. The company was founded by T. O'Brien in 1970 and is headquartered in Dublin, Ireland. | Health Technology |
| Eurogenerics NV | |
NeoCare NV
 NeoCare NV Pharmaceuticals: MajorHealth Technology Part of STADA Arzneimittel AG, NeoCare NV is a Belgian company that manufactures and supplies pharmaceuticals. The company is based in Brussels, Belgium. | Health Technology |
| OY Stada Pharma AB | |
| SFS International Ltd. | |
| STADA Financial Investments Ltd. | |
| STADApharm AB | |
| STADA Pharmaceuticals (Asia) Ltd. | |
| Stada Vietnam J.V. Co. Ltd. |
- Stock Market
- Insiders
- Hartmut Retzlaff
